Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures.

Hitomi TakadaMasayuki KurosakiHiroyuki NakanishiYuka TakahashiJun ItakuraKaoru TsuchiyaYutaka YasuiNobuharu TamakiKenta TakauraYasuyuki KomiyamaMayu HiguchiYouhei KubotaWann WangMao OkadaTakao ShimizuKeiya WatakabeNobuyuki EnomotoNamiki Izumi

Published in: PloS one (2019)

Lusutrombopag is an effective and safe drug for thrombocytopenia in cirrhotic patients, and can reduce the frequency of platelet transfusions.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
emergency department
peripheral blood
electronic health record